what are glp-1 drugs and Weight Loss GLP-1 Medications for Weight Loss:
Description
7 As the benefits of the GLP-1 receptor agonists with T2D, obesity, and cardiovascular health are becoming widely known, research into using these agents to treat other conditions has accelerated

9-13 There are also GLP-1 and GIP receptors in the central nervous system, and their binding suppresses appetite and increases the sensation of being full

Abstract Cardiovascular events related to atherosclerosis are responsible for high morbidity and mortality among patients with type 2 diabetes
Obese people who lose a lot of weight rapidly can develop facial drooping

Semaglutide has a cumulative exposure of over 22 million patient-years." "We will continue to invest in a variety of disease states including diabetes, chronic kidney disease, obesity, CV disease, liver disease, and Alzheimers disease, as seen in our robust clinical development programs and outcome studies," the statement continued

Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration
